Institute of Hematology

血研所 · Harbin First Hospital, Harbin

Established in 1965, the Institute of Hematology at Harbin First Hospital specializes in treating blood disorders, particularly leukemia. The department introduced chemotherapy for leukemia in 1974 and began hematopoietic stem cell transplantation in laminar flow wards in 1989. It utilizes arsenic trioxide combined with sequential therapy, a protocol adopted internationally in 1996. The institute employs MICM classification for leukemia diagnosis and conducts genetic research, including the identification of BCR/ABL gene fusion. It serves as a training base for master's degree students from twelve medical universities. The team has undertaken numerous national and international research projects and published extensively in domestic and international journals.

Conditions and treatments

Key facts

Rewritten in English from the department's own description on a public doctor-listing platform. Claims such as "leading" are the hospital's own.

Doctors listed17
Chief physicians7

Senior doctors

Chief and associate chief physicians listed for this department on public doctor-listing platforms (2025–2026).

Chief physicians

We are an independent coordination service, not part of this hospital. Names and titles change; the hospital's website is the final word. How we build this directory.

Need a specialist's opinion?

Send your records and question. We find a specialist in the right field who reviews your case and tells you what they recommend.

Contact us